| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |